EdwardsLifesciences✅Pro:Lowerslong-termcostsPro:Lowerslong-termcosts“CaseStudyMentioned”“CaseStudyMentioned”ID&E: Riskof bias intechnologyadoption“Innovation”Con:AntitrustchallengesThoratec🌎ID&E:Could createglobaldisparities❌Con:Antitrustchallenges✅Pro:Encouragesefficiency❌Con:Raisescost forconsumers🌎ID&E:Risk of biasintechnologyadoption🌎ID&E:RegulatoryoversightprotectsfairnessID&E:Impactsaffordabilityforunderservedpopulations✅Pro:CreatescompetitiveadvantageJenaValveTAVR-ARdevicePro:Improvespatientoutcomes❌Con:ReducescompetitionID&E: CouldcreateglobaldisparitiesPro:PromotesfasterdevelopmentPro:CreatescompetitiveadvantagePro:Expandstreatmentoptions🌎ID&E:Opportunityto designfor inclusion❌Con:StiflessmallercompetitorsCon: Canlimitinnovation (ifmonopolized)✅Pro:Expandstreatmentoptions🌎ID&E:Increasesaccess tolife-savingdevicesPro:DrivesinnovationCon: Stiflessmallercompetitors❌Con: Canlimitinnovation (ifmonopolized)“Antitrust”Con:ReducescompetitionHeartWare“Innovation”✅Pro:PromotesfasterdevelopmentCon:Potential jobloss insmaller firms“Antitrust”🌎ID&E:Impactsaffordability forunderservedpopulationsCon:Raisescost forconsumers✅Pro:Drivesinnovation🌎ID&E:May reduceequitableaccess ifcosts rise✅Pro:ImprovespatientoutcomesID&E:Increasesaccess tolife-savingdevices❌Con:Potential jobloss insmaller firms❌Con:Risk ofmarketmonopolyID&E: Mayreduceequitableaccess ifcosts riseCon: Riskof marketmonopolyID&E:Opportunityto designfor inclusionPro:EncouragesefficiencyID&E:RegulatoryoversightprotectsfairnessEdwardsLifesciences✅Pro:Lowerslong-termcostsPro:Lowerslong-termcosts“CaseStudyMentioned”“CaseStudyMentioned”ID&E: Riskof bias intechnologyadoption“Innovation”Con:AntitrustchallengesThoratec🌎ID&E:Could createglobaldisparities❌Con:Antitrustchallenges✅Pro:Encouragesefficiency❌Con:Raisescost forconsumers🌎ID&E:Risk of biasintechnologyadoption🌎ID&E:RegulatoryoversightprotectsfairnessID&E:Impactsaffordabilityforunderservedpopulations✅Pro:CreatescompetitiveadvantageJenaValveTAVR-ARdevicePro:Improvespatientoutcomes❌Con:ReducescompetitionID&E: CouldcreateglobaldisparitiesPro:PromotesfasterdevelopmentPro:CreatescompetitiveadvantagePro:Expandstreatmentoptions🌎ID&E:Opportunityto designfor inclusion❌Con:StiflessmallercompetitorsCon: Canlimitinnovation (ifmonopolized)✅Pro:Expandstreatmentoptions🌎ID&E:Increasesaccess tolife-savingdevicesPro:DrivesinnovationCon: Stiflessmallercompetitors❌Con: Canlimitinnovation (ifmonopolized)“Antitrust”Con:ReducescompetitionHeartWare“Innovation”✅Pro:PromotesfasterdevelopmentCon:Potential jobloss insmaller firms“Antitrust”🌎ID&E:Impactsaffordability forunderservedpopulationsCon:Raisescost forconsumers✅Pro:Drivesinnovation🌎ID&E:May reduceequitableaccess ifcosts rise✅Pro:ImprovespatientoutcomesID&E:Increasesaccess tolife-savingdevices❌Con:Potential jobloss insmaller firms❌Con:Risk ofmarketmonopolyID&E: Mayreduceequitableaccess ifcosts riseCon: Riskof marketmonopolyID&E:Opportunityto designfor inclusionPro:EncouragesefficiencyID&E:Regulatoryoversightprotectsfairness

Competitive Technology - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
  1. Edwards Lifesciences
  2. ✅Pro: Lowers long-term costs
  3. Pro: Lowers long-term costs
  4. “Case Study Mentioned”
  5. “Case Study Mentioned”
  6. ID&E: Risk of bias in technology adoption
  7. “Innovation”
  8. Con: Antitrust challenges
  9. Thoratec
  10. 🌎ID&E: Could create global disparities
  11. ❌Con: Antitrust challenges
  12. ✅Pro: Encourages efficiency
  13. ❌Con: Raises cost for consumers
  14. 🌎ID&E: Risk of bias in technology adoption
  15. 🌎ID&E: Regulatory oversight protects fairness
  16. ID&E:Impacts affordability for underserved populations
  17. ✅Pro: Creates competitive advantage
  18. JenaValve
  19. TAVR-AR device
  20. Pro: Improves patient outcomes
  21. ❌Con: Reduces competition
  22. ID&E: Could create global disparities
  23. Pro: Promotes faster development
  24. Pro: Creates competitive advantage
  25. Pro: Expands treatment options
  26. 🌎ID&E: Opportunity to design for inclusion
  27. ❌Con: Stifles smaller competitors
  28. Con: Can limit innovation (if monopolized)
  29. ✅Pro: Expands treatment options
  30. 🌎ID&E: Increases access to life-saving devices
  31. Pro: Drives innovation
  32. Con: Stifles smaller competitors
  33. ❌Con: Can limit innovation (if monopolized)
  34. “Antitrust”
  35. Con: Reduces competition
  36. HeartWare
  37. “Innovation”
  38. ✅Pro: Promotes faster development
  39. Con: Potential job loss in smaller firms
  40. “Antitrust”
  41. 🌎ID&E:Impacts affordability for underserved populations
  42. Con: Raises cost for consumers
  43. ✅Pro: Drives innovation
  44. 🌎ID&E: May reduce equitable access if costs rise
  45. ✅Pro: Improves patient outcomes
  46. ID&E: Increases access to life-saving devices
  47. ❌Con: Potential job loss in smaller firms
  48. ❌Con: Risk of market monopoly
  49. ID&E: May reduce equitable access if costs rise
  50. Con: Risk of market monopoly
  51. ID&E: Opportunity to design for inclusion
  52. Pro: Encourages efficiency
  53. ID&E: Regulatory oversight protects fairness